Stem Cell Types and Therapeutic Potential | 干细胞类型与应用前景

📚 Stem Cell Types and Therapeutic Potential | 干细胞类型与应用前景

Stem cells are undifferentiated biological cells that can differentiate into specialised cells and divide to produce more stem cells. They are central to development, tissue repair, and the emerging field of regenerative medicine.

干细胞是一类未分化的生物细胞，既能分化形成特化细胞，也能通过分裂产生更多的干细胞。它们在个体发育、组织修复以及新兴的再生医学领域中处于核心地位。

1. Key Properties of Stem Cells | 干细胞的关键特性

Two defining properties distinguish stem cells from other cell types. The first is self-renewal, the ability to undergo numerous mitotic divisions while maintaining an undifferentiated state. The second is potency, the capacity to differentiate into one or more specialised cell types under appropriate signals.

两大核心特性将干细胞与其他细胞类型区分开来。第一是自我更新能力，即经历多次有丝分裂的同时保持未分化状态的能力；第二是分化潜能，即在适当信号下分化形成一种或多种特化细胞类型的能力。

Asymmetric cell division produces one stem cell and one progenitor cell committed to differentiation. This mechanism balances the maintenance of the stem cell pool with the production of differentiated progeny.

不对称细胞分裂会产生一个干细胞和一个已定向分化的祖细胞。这种机制既维持了干细胞库的稳定，又产生了分化的子代细胞。

Stem cell = Self-renewal + Potency
干细胞 = 自我更新 + 分化潜能

2. Classification by Potency | 按分化潜能分类

Potency describes the range of cell types a stem cell can form. The classification is hierarchical, from totipotent to unipotent.

分化潜能描述干细胞所能形成的细胞类型范围。该分类具有层级性，从全能性到单能性依次排列。

Type 类型	Potential 潜能	Example 示例
Totipotent 全能	All cell types + extra-embryonic tissues 所有细胞类型 + 胚胎外组织	Zygote, early blastomeres 受精卵、早期卵裂球
Pluripotent 多能	All three germ layers 所有三个胚层	Embryonic stem cells 胚胎干细胞
Multipotent 多潜能	Several related cell types 若干相关细胞类型	Haematopoietic stem cells 造血干细胞
Unipotent 单能	One cell type 仅一种细胞类型	Spermatogonial stem cells 精原干细胞

Totipotent cells can form an entire organism, including the trophoblast that gives rise to the placenta. Pluripotent cells cannot form extra-embryonic tissues but can produce all embryonic cell types.

全能干细胞能够形成完整生物体，包括发育为胎盘的滋养层。多能干细胞虽然不能形成胚胎外组织，但能够产生所有胚胎细胞类型。

3. Embryonic Stem Cells | 胚胎干细胞

Embryonic stem cells (ESCs) are derived from the inner cell mass of a blastocyst, approximately four to five days after fertilisation. These cells are pluripotent, meaning they can differentiate into cells of the ectoderm, mesoderm, and endoderm.

胚胎干细胞来源于囊胚的内细胞团，大约在受精后第四至五天。这些细胞具有多能性，能够分化成为外胚层、中胚层和内胚层的细胞。

ESCs are cultured in vitro under strictly controlled conditions. Key culture requirements include a feeder layer or defined medium, growth factors such as leukaemia inhibitory factor (LIF), and a suitable substrate to prevent spontaneous differentiation.

胚胎干细胞在体外培养时需要严格控制条件。关键的培养要求包括饲养层或成分明确的培养基、白血病抑制因子等生长因子，以及防止自发分化的适宜底物。

The ability to differentiate into any somatic cell type makes ESCs a powerful model for studying early human development and a potential source of cells for transplantation therapy.

胚胎干细胞能够分化成任何体细胞类型，这使其成为研究人类早期发育的有力模型，也是移植治疗中潜在的细胞来源。

4. Adult Stem Cells | 成体干细胞

Adult stem cells, also called somatic stem cells, are found in small quantities in various tissues, including bone marrow, skin, liver, and brain. They maintain and repair the tissue in which they reside.

成体干细胞又称体干细胞，少量存在于骨髓、皮肤、肝脏和大脑等多种组织中。它们负责维持和修复所在的组织。

Haematopoietic stem cells (HSCs) in bone marrow give rise to all blood cell types: erythrocytes, lymphocytes, neutrophils, and platelets. Mesenchymal stem cells (MSCs) in bone marrow can differentiate into bone, cartilage, fat, and muscle cells.

骨髓中的造血干细胞能够产生所有血细胞类型：红细胞、淋巴细胞、中性粒细胞和血小板。骨髓中的间充质干细胞则可分化为骨、软骨、脂肪和肌肉细胞。

Adult stem cells are typically multipotent rather than pluripotent. They are less versatile than embryonic stem cells but avoid many ethical objections because their isolation does not destroy an embryo.

成体干细胞通常是多潜能的，而非多能的。它们的分化能力不如胚胎干细胞广泛，但因其获取过程不破坏胚胎，从而规避了许多伦理争议。

5. Induced Pluripotent Stem Cells | 诱导多能干细胞

Induced pluripotent stem cells (iPSCs) are somatic cells that have been genetically reprogrammed to an embryonic-like pluripotent state. Takahashi and Yamanaka first generated mouse iPSCs in 2006, followed by human iPSCs in 2007.

诱导多能干细胞是经基因重编程而恢复到类胚胎多能状态的体细胞。2006年，高桥和山中伸弥首次成功制备小鼠诱导多能干细胞，2007年又制备出人类诱导多能干细胞。

Reprogramming uses viral vectors to deliver four transcription factors: Oct4, Sox2, Klf4, and c-Myc. These proteins activate the pluripotency gene network and silence somatic cell genes.

重编程通常使用病毒载体导入四种转录因子：Oct4、Sox2、Klf4和c-Myc。这些蛋白质能够激活多能性基因网络，同时沉默体细胞基因。

Fibroblast + Oct4/Sox2/Klf4/c-Myc → iPSC
成纤维细胞 + 四种转录因子 → 诱导多能干细胞

Because iPSCs can be generated from a patient’s own cells, they offer the possibility of personalised cell therapy with reduced risk of immune rejection. However, the use of integrating viral vectors carries a risk of insertional mutagenesis, which may activate oncogenes.

由于诱导多能干细胞可以从患者自身细胞制备，因此能够实现个体化细胞治疗，并降低免疫排斥风险。然而，整合性病毒载体的使用存在插入突变风险，可能激活致癌基因。

6. Sources of Stem Cells | 干细胞的来源

Stem cells can be obtained from multiple sources, each with distinct advantages and limitations.

干细胞可以从多种来源获取，每种来源都有其独特的优势和局限。

Embryonic: inner cell mass of blastocyst (5 days post-fertilisation), from surplus IVF embryos or somatic cell nuclear transfer.

胚胎来源：囊胚内细胞团（受精后第5天），来自试管婴儿剩余胚胎或体细胞核移植。
Foetal: tissues of aborted foetuses, including umbilical cord blood and placenta, rich in HSCs.

胎儿来源：流产胎儿的组织，包括脐带血和胎盘，富含造血干细胞。
Adult: bone marrow, adipose tissue, dental pulp, and other tissues; obtained via biopsy, minimally invasive.

成体来源：骨髓、脂肪组织、牙髓等组织；通过活检获取，创伤较小。
Patient-derived iPSCs: skin fibroblasts or blood cells reprogrammed in vitro.

患者自体诱导多能干细胞：取皮肤成纤维细胞或血细胞在体外进行重编程。

7. Therapeutic Applications in Current Medicine | 当前医学治疗应用

Haematopoietic stem cell transplantation is the most established stem cell therapy. It treats leukaemia, lymphoma, and certain autoimmune disorders by replacing defective bone marrow with healthy HSCs from a donor.

造血干细胞移植是最成熟的干细胞疗法。该方法通过将健康供者的造血干细胞替代病变骨髓，用于治疗白血病、淋巴瘤及某些自身免疫性疾病。

Corneal limbal stem cell transplantation restores vision in patients with corneal damage. Skin stem cell grafts are used to treat severe burns by growing autologous epidermal sheets in vitro.

角膜缘干细胞移植可修复角膜损伤患者的视力。皮肤干细胞移植通过体外培养自体表皮片，用于治疗严重烧伤。

Mesenchymal stem cells are being investigated in clinical trials for osteoarthritis, inflammatory bowel disease, and graft-versus-host disease due to their immunomodulatory properties.

间充质干细胞因其免疫调节特性，目前正在骨关节炎、炎症性肠病和移植物抗宿主病的临床试验中接受评估。

8. Regenerative Medicine and Future Prospects | 再生医学与未来前景

Regenerative medicine aims to replace or regenerate damaged tissues and organs using stem cells, biomaterials, and growth factors. This field holds promise for conditions that currently lack effective treatments.

再生医学旨在利用干细胞、生物材料和生长因子来替换或再生受损的组织和器官。该领域为目前缺乏有效治疗手段的疾病带来了希望。

Type 1 diabetes could be treated by transplanting insulin-producing β-cells derived from iPSCs or ESCs. Clinical trials of encapsulated β-cell replacement have shown encouraging early results.

1型糖尿病有望通过移植由诱导多能干细胞或胚胎干细胞分化而来的胰岛素产生β细胞进行治疗。封装型β细胞替代疗法的临床试验已显示出令人鼓舞的早期结果。

Parkinson’s disease involves the loss of dopaminergic neurons in the substantia nigra. Pluripotent stem cells can be directed to differentiate into midbrain dopaminergic neurons, which when transplanted into the striatum may restore motor function.

帕金森病的病理特征是中脑黑质多巴胺能神经元的丧失。多能干细胞可被定向分化为中脑多巴胺能神经元，将其移植到纹状体后有望恢复运动功能。

Spinal cord injury research focuses on transplanting neural stem cells or oligodendrocyte progenitor cells to remyelinate damaged axons and promote functional recovery.

脊髓损伤研究聚焦于移植神经干细胞或少突胶质祖细胞，以修复受损轴突的髓鞘并促进功能恢复。

9. Organoid Culture and Disease Modelling | 类器官培养与疾病模型

Stem cells can self-organise into three-dimensional structures called organoids, which mimic the architecture and function of real organs. Intestinal, cerebral, liver, and kidney organoids have been generated.

干细胞能够自组织形成三维结构，即类器官，这些结构可以模拟真实器官的构造和功能。目前已成功构建肠、脑、肝和肾等类器官。

Organoids derived from patient iPSCs preserve the disease-causing genetic background, making them valuable for studying genetic disorders, testing drug toxicity, and screening personalised therapies.

由患者诱导多能干细胞形成的类器官保留了致病的遗传背景，使其在研究遗传性疾病、检测药物毒性以及筛选个体化治疗方面具有重要价值。

CRISPR-Cas9 gene editing can correct disease-causing mutations in iPSCs before differentiation, enabling gene-corrected autologous cell therapy to be explored.

CRISPR-Cas9基因编辑技术可以在诱导多能干细胞分化前修复致病突变，从而为基因校正的自体细胞治疗研究开辟了道路。

10. Ethical and Regulatory Considerations | 伦理与监管考量

The use of embryonic stem cells raises significant ethical concerns because the isolation process destroys the blastocyst, which some consider a human life. Regulations vary widely between countries, with some permitting research under strict licence and others prohibiting it entirely.

胚胎干细胞的使用引发重大伦理争议，因为其分离过程会破坏囊胚，而部分人认为囊胚具有生命意义。各国监管政策差异显著：有些国家在严格许可下允许此类研究，而另一些国家则完全禁止。

Key ethical issues include the moral status of the embryo, informed consent from donors of surplus embryos, the commodification of human tissues, and equitable access to resulting therapies.

核心伦理问题包括胚胎的道德地位、剩余胚胎捐赠者的知情同意、人体组织的商品化，以及治疗成果的公平可及性。

iPSCs bypass embryo destruction, but they introduce concerns of tumour formation and genetic instability. Responsible translation requires stringent quality control, long-term animal studies, and phased clinical trials.

诱导多能干细胞避开了胚胎破坏问题，但带来了肿瘤形成和遗传不稳定性的担忧。负责任的临床转化需要有严格的质量控制、长期动物研究以及分阶段临床试验。

11. Challenges and Limitations | 挑战与局限性

Despite their promise, stem cell therapies face substantial scientific hurdles. Teratoma formation is a major safety concern when transplanting pluripotent cells, as undifferentiated cells can form benign tumours containing multiple tissue types.

尽管前景广阔，干细胞疗法仍面临重大的科学障碍。畸胎瘤形成是多能细胞移植中的主要安全隐患，因为未分化细胞可能形成含多种组织类型的良性肿瘤。

Controlling differentiation efficiency and purity is challenging. Clinical-grade cell populations must be free of undifferentiated cells and maintain stable karyotypes through prolonged culture.

控制分化效率和纯度具有挑战性。临床级细胞群体必须不含未分化细胞，并且经过长期培养后仍保持稳定的核型。

Immune rejection, although reduced for autologous therapies, remains relevant for allogeneic ESC-derived products. Moreover, scale-up production of clinical-grade cells is expensive and technically demanding.

免疫排斥问题虽然在同种自体治疗中有所减少，但在异体胚胎干细胞来源的制品中仍然存在。此外，临床级细胞的大规模生产成本高昂且技术要求极高。

12. Conclusion | 结论

Stem cells represent a cornerstone of modern biology and regenerative medicine. The classification from totipotent to unipotent describes a hierarchy of developmental potential, while ESCs, adult stem cells, and iPSCs offer complementary sources for research and therapy.

干细胞是现代生物学与再生医学的基石。从全能性到单能性的分类描述了发育潜能的层级结构，而胚胎干细胞、成体干细胞和诱导多能干细胞为科研和治疗提供了互补的细胞来源。

Established treatments such as bone marrow transplantation save lives today, while emerging applications in diabetes, neurodegeneration, and organ repair are advancing through clinical trials. The future of stem cell medicine will depend on mastering safety, standardisation, and equitable access.

骨髓移植等成熟疗法如今已在挽救生命，而糖尿病、神经退行性疾病和器官修复等新兴应用正在通过临床试验不断推进。干细胞医学的未来将取决于能否解决安全性、标准化和公平可及性三大问题。

Published by TutorHao | Biology Revision Series | aleveler.com

更多咨询请联系16621398022（同微信）

Stem Cell Types and Therapeutic Potential | 干细胞类型与应用前景